Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caelyx and Cyclophosphamide in Metastatic Breast Cancer
NCT00779129Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2003
- Primary completion
- Aug 2007
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in breast cancer, sponsored by Merck & Co.. Started Mar 2003; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00779129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00779129.